HPV Testing and Pap Test Market Gains Momentum With Evolving Screening Technologies
The hpv and pap testing market is expanding steadily as healthcare systems prioritize cervical cancer prevention, early diagnosis, and broader screening access. HPV testing helps identify high-risk human papillomavirus infections linked to cervical cancer, while Pap testing detects abnormal cervical cells that may signal precancerous changes. According to DelveInsight, the global market was valued at approximately USD 3,702.30 million in 2025 and is expected to reach USD 6,524.39 million by 2034, growing at a CAGR of 6.56% during 2026–2034. Cervical Cancer Burden Drives the HPV Testing and Pap Test Market The growing incidence of cervical cancer is an important factor contributing to the expansion of the hpv testing and pap test market . Persistent infection with oncogenic HPV types remains the primary cause of cervical cancer, while many infections may remain undetected because they do not initially produce noticeable symptoms. Regular screening therefore plays a critical role...